The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MSK-ACCESS for noninvasive somatic mutation profiling of lung cancers utilizing circulating tumor DNA.
 
Emily S. Lebow
No Relationships to Disclose
 
Yonina R. Murciano-Goroff
Travel, Accommodations, Expenses - AstraZeneca
 
Angela Rose Brannon
Stock and Other Ownership Interests - Johnson & Johnson
 
Ahmet Zehir
Honoraria - Illumina
 
Maria E. Arcila
Honoraria - Biocartis; Invivoscribe
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Invivoscribe; Raindance Technologies
 
Ryma Benayed
No Relationships to Disclose
 
Jamie E. Chaft
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Merck
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst)
 
Alexander E. Drilon
Honoraria - Foundation Medicine; Medscape; MORE Health; OncLive; Peerview; PeerVoice; Physicans' Education Resource; Research to Practice; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; BerGenBio; Blueprint Medicines; Exelixis; Genentech/Roche; Helsinn Therapeutics; Hengrui Therapeutics; Ignyta; Lilly; Loxo; MORE Health; Pfizer; Takeda/Millennium; TP Therapeutics; Tyra Biosciences; Verastem; Verastem
Research Funding - Foundation Medicine
Patents, Royalties, Other Intellectual Property - Wolters Kluwer (Royalties for Pocket Oncology)
Other Relationship - GlaxoSmithKline; Merck; Pfizer; PharmaMar; Puma Biotechnology; Taiho Pharmaceutical; Teva
 
Mark G. Kris
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Pfizer; Regeneron
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche; Pfizer
Other Relationship - Memorial Sloan-Kettering Cancer Center
 
Daniel Richard Gomez
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck; Reflexion Medical; US Oncology; Varian Medical Systems; Vindico Medical Education
Speakers' Bureau - Bristol-Myers Squibb; Varian Medical Systems
Research Funding - AstraZeneca; Bristol-Myers Squibb; Merck; Varian Medical Systems
Travel, Accommodations, Expenses - AstraZeneca; Driver, Inc; Merck; US Oncology; Varian Medical Systems; Vindico Medical Education
 
Pedram Razavi
Consulting or Advisory Role - AstraZeneca; Foundation Medicine; Novartis
Research Funding - GRAIL (Inst); Illumina (Inst)
Travel, Accommodations, Expenses - Epic Sciences; Guardant Health
 
Jorge S. Reis-Filho
Consulting or Advisory Role - Genentech/Roche; Goldman Sachs; Invicro; Novartis; Paige.AI; Repare Therapeutics; Ventana Medical Systems; Volition RX
 
David Randolph Jones
Consulting or Advisory Role - AstraZeneca; Diffusion Pharmaceuticals; Merck
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; Amgen; Ascentage Pharma; AstraZeneca; Bicycle Therapeutics; Bridge Medicines; Celgene; Daiichi Sankyo; Genentech/Roche; Harpoon Therapeutics; Ipsen; Loxo; PharmaMar; PharmaMar
Research Funding - Abbvie/Stemcentrx (Inst); Daiichi Sankyo (Inst); Merck (Inst); Viralytics (Inst)
 
James M. Isbell
Stock and Other Ownership Interests - LumaCyte
 
David B. Solit
Stock and Other Ownership Interests - Loxo
Consulting or Advisory Role - Illumina; Intezyne Technologies; Lilly; Loxo; Pfizer; QED Therapeutics; Vividion Therapeutics
Travel, Accommodations, Expenses - Merck KGaA
 
Marc Ladanyi
Honoraria - Merck (I)
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Merck (I); NCCN/AstraZeneca; Takeda
Research Funding - Helsinn Therapeutics; Loxo (Inst)
 
Dana Tsui
Honoraria - Cambridge Healthtech Institute; Nanodigmbio
Other Relationship - Cambridge Healthtech Institute; Nanodigmbio
 
Michael F. Berger
Consulting or Advisory Role - Roche
Research Funding - Grail
 
Bob T. Li
Consulting or Advisory Role - Guardant Health; Hengrui Therapeutics
Research Funding - Amgen (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); GRAIL (Inst); Guardant Health (Inst); Hengrui Therapeutics (Inst); Lilly (Inst); MORE Health (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - US62/514,661 (Inst); US62/685,057 (Inst)